A Phase I/ Randomized Phase II Trial Of Oxaliplatin (NSC #266046) With Or Without ZD 1839 (NSC # 715055) In Patients With Advanced Colorectal Carcinoma
Latest Information Update: 13 Feb 2013
At a glance
- Drugs Gefitinib (Primary) ; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Sep 2005 New trial record.